Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
Fam Court Rev ; 60(2): 241-258, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35601197

ABSTRACT

The COVID-19 pandemic has profoundly affected families and children involved in Ontario's family justice system as well as family justice professionals in the province. In a span of two years, Ontario's family justice system has been fundamentally transformed, from a paper-based, in-person system to a paperless system in which many services, including judicial proceedings, continue to be largely delivered remotely. We report on the findings of two studies on the impact of the COVID-19 pandemic on Ontario family justice: (1) an analysis of early pandemic court decisions; and (2) a survey of family justice professionals about their experiences during the early pandemic. We describe how the pandemic has exacerbated access to justice issues for certain groups, including families experiencing high conflict, victims of intimate partner violence, families involved in child welfare proceedings, and self-represented litigants, while improving access to justice for others by improving efficiency and reducing legal costs. As Ontario moves past the pandemic, the family justice system will need to ensure that technological advances improve access to justice for all court-involved families.

2.
J Am Acad Dermatol ; 58(3): 488-9, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18280347

ABSTRACT

Radiocontrast agents are known to be the cause of many cutaneous manifestations. The present report describes a unique case of a Sweet's syndrome-like neutrophilic dermatosis that recurred three times over 5 years following administration of a radiocontrast agent administered during the course of an intravenous pyelography.


Subject(s)
Contrast Media/adverse effects , Iothalamate Meglumine/adverse effects , Kidney Calculi/diagnostic imaging , Skin Diseases/chemically induced , Sweet Syndrome/chemically induced , Urography , Aged , Aged, 80 and over , Contrast Media/administration & dosage , Humans , Injections, Intravenous , Iothalamate Meglumine/administration & dosage , Remission, Spontaneous , Skin Diseases/pathology , Skin Diseases/physiopathology , Sweet Syndrome/pathology , Sweet Syndrome/physiopathology
3.
Cancer ; 106(2): 413-9, 2006 Jan 15.
Article in English | MEDLINE | ID: mdl-16353205

ABSTRACT

BACKGROUND: Classic Kaposi sarcoma (CKS) is a relatively rare vascular disease primarily affecting human immunodeficiency virus (HIV)-uninfected elderly men. The infection with Kaposi sarcoma-associated herpesvirus (KSHV) is necessary for the establishment of Kaposi sarcoma (KS), although it is not sufficient. Thus, only a small fraction of KSHV-infected individuals develops KS. The cofactors that influence risk of KS among HIV-uninfected individuals are yet to be determined. The objective of the current study was to assess potential risk factors for CKS in the KSHV-infected Jewish population in Israel. METHODS: A case-control study involved 35 CKS cases and 48 matched KSHV-infected controls. Lifestyle and medical history data from case patients and controls were compared by logistic regression analysis. RESULTS: In a multivariate analysis, the authors identified an age-related small increased risk for CKS in subjects originating from Asia and Africa. The risk for CKS increased, although not significantly statistically, in subjects who reported alcohol consumption, diabetes mellitus, herpes simplex, and asthma. No relation was found with cigarette smoking, family size, number of lifetime sexual partners, or sexually transmitted disease. CONCLUSIONS: A borderline increase in CKS risk among elderly subjects originating from Africa or Asia was identified. These results need to be further evaluated by larger studies. The authors believe that genetic and immunologic parameters may alter risk for CKS and, therefore, should also be investigated.


Subject(s)
Antibodies, Viral/blood , Habits , Herpesvirus 8, Human/immunology , Sarcoma, Kaposi/epidemiology , Sarcoma, Kaposi/virology , Adult , Age Factors , Aged , Aged, 80 and over , Case-Control Studies , Female , Humans , Israel , Male , Middle Aged , Quality of Life , Risk Factors
4.
Arch Dermatol ; 141(11): 1429-34, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16301390

ABSTRACT

BACKGROUND: Classic Kaposi's sarcoma (CKS) primarily affects elderly Mediterranean or Eastern European men. Incidence rates of CKS in Israel are among the world's highest. In practically all cases, antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) can be detected. A relatively high seroprevalence rate of KSHV in Israel generally correlates with the incidence of CKS. A sexual mode of virus transmission is recognized among homosexual men, whereas the precise transmission routes in the heterosexual population and those with CKS are still unclear. OBJECTIVE: To better assess the transmission routes of KSHV in Israeli patients with CKS and their first-degree relatives as compared with a control group. DESIGN: Serum was collected from all study participants and tested for KSHV antibodies by means of latent and lytic immunofluorescence assays. An open reading frame 65 (ORF65) Western blot assay was applied as a confirmatory tool. SETTING: Three dermatological departments in Israel. PATIENTS: Sixty-four Jewish patients with CKS, 143 of their first-degree relatives, and 186 hospital-based control subjects. RESULTS: Seropositivity to KSHV was detected in 62 (96.9%) of the patients with CKS, in 56 (39.2%) of their first-degree relatives, and in only 21 (11.3%) of the hospital controls (P<.001). The specific relationship with the index patient (spouse, offspring, or sibling) had no significant effect on the prevalence of serpositivity in the family members. CONCLUSION: Our serologic evidence of familial clustering of KSHV infection suggests a predominantly nonsexual horizontal transmission route of the virus.


Subject(s)
Disease Transmission, Infectious/statistics & numerical data , Herpesvirus 8, Human/isolation & purification , Sarcoma, Kaposi/epidemiology , Sarcoma, Kaposi/virology , Adolescent , Adult , Aged , Antibodies, Viral/analysis , Case-Control Studies , Family , Female , Herpesvirus 8, Human/immunology , Humans , Israel/epidemiology , Male , Middle Aged , Registries , Sarcoma, Kaposi/blood , Seroepidemiologic Studies
5.
J Nutr Educ Behav ; 36(3): 135-7, 2004.
Article in English | MEDLINE | ID: mdl-15202989

ABSTRACT

OBJECTIVE: To evaluate the efficacy of a nutrition education intervention for college female athletes to improve nutrition knowledge, build self-efficacy with respect to making healthful dietary choices, and improve dietary intake. DESIGN: A pretest-posttest control group design was implemented. PARTICIPANTS: A women's soccer team (n =15) and a women's swim team (n = 15) were randomly assigned to experimental and control groups, respectively. INTERVENTION: The intervention focused on nutrition knowledge, self-efficacy in making healthful dietary choices, and dietary practices to demonstrate treatment effect. MAIN OUTCOME MEASURES: Dependent variables were nutrition knowledge, self-efficacy, and dietary practices. Independent variables were group assignment. ANALYSES: The Mann-Whitney U test was used to analyze the results between groups, and the Fisher exact probability test was used to detect differences between groups in the number of positive dietary changes. RESULTS: Treatment participants significantly improved nutrition knowledge, self-efficacy (P <.05), and the overall number of positive dietary changes (P <.03). CONCLUSIONS: This study reduces the paucity of nutrition education intervention research among athletes and demonstrates the ability to increase not only nutrition knowledge, which is typically reported, but also self-efficacy and improvement in overall positive dietary changes during an 8-week intervention.


Subject(s)
Diet/standards , Nutritional Sciences/education , Self Efficacy , Soccer/physiology , Swimming/physiology , Adult , Diet Records , Female , Health Knowledge, Attitudes, Practice , Humans , Soccer/psychology , Surveys and Questionnaires , Swimming/psychology
6.
J Infect Dis ; 189(11): 2023-6, 2004 Jun 01.
Article in English | MEDLINE | ID: mdl-15143469

ABSTRACT

It is widely accepted that there is a causal association between Kaposi sarcoma-associated herpesvirus (KSHV) and Kaposi sarcoma (KS). However, the majority of individuals infected with KSHV never develop KS. Here, we present a unique familial case of classic KS, in which the disease occurs in 4 siblings who have no recognized underlying immunodeficiency. We examine risk factors that could play a role in this condition, including KSHV infection, KSHV DNA load, genetic variants of KSHV, infection with additional viruses, interleukin-6-promoter polymorphism, and HLA genotype. We hypothesize that a genetic susceptibility to KS, in combination with KSHV infection, may play an important role in the presented familial case.


Subject(s)
Herpesvirus 8, Human , Sarcoma, Kaposi/genetics , Adult , Aged , Aged, 80 and over , Antibodies, Viral/blood , DNA, Viral/blood , Female , Genetic Predisposition to Disease , Histocompatibility Antigens Class I/genetics , Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens Class II/genetics , Histocompatibility Antigens Class II/immunology , Humans , Interleukin-6/genetics , Interleukin-6/immunology , Male , Middle Aged , Pedigree , Polymorphism, Genetic/immunology , Promoter Regions, Genetic/immunology , Sarcoma, Kaposi/immunology , Sarcoma, Kaposi/virology
7.
Cancer ; 95(9): 1982-7, 2002 Nov 01.
Article in English | MEDLINE | ID: mdl-12404293

ABSTRACT

BACKGROUND: Classical Kaposi sarcoma (CKS) is a rare indolent neoplasm that is particularly prevalent among Jews of Ashkenazi and Mediterranean origin. Data regarding prognostic factors for CKS are scarce. The aim of the current retrospective analysis was to better define prognostic subgroups among patients with CKS. METHODS: Between 1960 and 1995, 248 consecutive patients with CKS were treated at the Rambam and Rabin Medical Centers in Israel. Although treatment options included local excision, radiotherapy, and chemotherapy, observation alone was used for 31% of patients. For prognostic factor analysis, disease progression was classified as any progression and dissemination, and progression-free survival was calculated for each. RESULTS: At a median follow-up of 20 months, four patients (1.6%) died of CKS. Of the patients eligible for analysis, 94 of 220 (39%) had any progression and 23 of 120 (18%) had dissemination. Only 8 of 202 (4%) had visceral spread. On univariate analysis, age was a statistically significant prognostic factor for any progression (P = 0.04), whereas immunosuppression and visceral involvement at presentation had only borderline significance. Immunosuppression was the only prognostic factor for dissemination (P = 0.003). On multivariate analysis, both age and immunosuppression were significant prognostic factors for any progression (P = 0.001 and 0.01, respectively). Immunosuppression was also predictive of dissemination (P = 0.006). CONCLUSIONS: Immunosuppression and older age (50 years and older) are strongly associated with poorer outcome among CKS patients. The two end points used in this study may be used for future prognostic factor analyses.


Subject(s)
Sarcoma, Kaposi , Adult , Aged , Aged, 80 and over , Disease Progression , Female , Humans , Immunocompromised Host , Male , Middle Aged , Multivariate Analysis , Prognosis , Proportional Hazards Models , Retrospective Studies , Risk Factors , Sarcoma, Kaposi/immunology , Sarcoma, Kaposi/mortality , Sarcoma, Kaposi/secondary , Sarcoma, Kaposi/therapy , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL